This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Csányi, E., Halász, M. Cross-resistance studies on 1,6-dibromo-dideoxy-D-mannitol(DBM)-resistant Yoshida S.C. sarcoma.. Br J Cancer 21, 353–357 (1967). https://doi.org/10.1038/bjc.1967.40
Issue Date:
DOI: https://doi.org/10.1038/bjc.1967.40
This article is cited by
-
Absence of cross-resistance between two alkylating agents: BCNU vs bifunctional galactitol
Cancer Chemotherapy and Pharmacology (1989)
-
Phase II evaluation of dibromodulcitol and actinomycin D, hydroxyurea, and cyclophosphamide in previously untreated patients with malignant melanoma
Investigational New Drugs (1987)
-
New drugs under clinical evaluation in the United States
Cancer Chemotherapy and Pharmacology (1978)